Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Varga

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Nature Medicine|January 9, 2009
Fixing a failed vaccineSteven M Varga
Current Opinion in Virology|May 6, 2014
Mucosal vaccines against respiratory syncytial virusKejian Yang, Steven M Varga
Frontiers in Immunology|April 27, 2019
Editorial: Orchestration of an Immune Response to Respiratory PathogensSteven M Varga, Andrea J Sant
Aging Health|February 23, 2010
Effects of aging on the adaptive immune response to respiratory virus infectionsRoss B Fulton, Steven M Varga
Vaccines|July 2, 2021
Considerations for a Respiratory Syncytial Virus Vaccine Targeting an Elderly PopulationLaura M Stephens, Steven M Varga
Virology|May 30, 2002
RSV-induced immunopathology: dynamic interplay between the virus and host immune responseSteven M Varga, Thomas J Braciale
Vaccines|April 16, 2020
Function and Modulation of Type I Interferons during Respiratory Syncytial Virus InfectionLaura M Stephens, Steven M Varga
Expert Review of Vaccines|October 11, 2008
Pulmonary immunity and immunopathology: lessons from respiratory syncytial virusMatthew R Olson, Steven M Varga
Future Virology|December 6, 2008
Overcoming T cell-mediated immunopathology to achieve safe RSV vaccinationElaine M Castilow, Steven M Varga
Future Virology|December 21, 2020
Nanoparticle vaccines against respiratory syncytial virusLaura M Stephens, Steven M Varga
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Nature Medicine|January 9, 2009
Fixing a failed vaccineSteven M Varga
Current Opinion in Virology|May 6, 2014
Mucosal vaccines against respiratory syncytial virusKejian Yang, Steven M Varga
Frontiers in Immunology|April 27, 2019
Editorial: Orchestration of an Immune Response to Respiratory PathogensSteven M Varga, Andrea J Sant
Aging Health|February 23, 2010
Effects of aging on the adaptive immune response to respiratory virus infectionsRoss B Fulton, Steven M Varga
Vaccines|July 2, 2021
Considerations for a Respiratory Syncytial Virus Vaccine Targeting an Elderly PopulationLaura M Stephens, Steven M Varga
Virology|May 30, 2002
RSV-induced immunopathology: dynamic interplay between the virus and host immune responseSteven M Varga, Thomas J Braciale
Vaccines|April 16, 2020
Function and Modulation of Type I Interferons during Respiratory Syncytial Virus InfectionLaura M Stephens, Steven M Varga
Expert Review of Vaccines|October 11, 2008
Pulmonary immunity and immunopathology: lessons from respiratory syncytial virusMatthew R Olson, Steven M Varga
Future Virology|December 6, 2008
Overcoming T cell-mediated immunopathology to achieve safe RSV vaccinationElaine M Castilow, Steven M Varga
Future Virology|December 21, 2020
Nanoparticle vaccines against respiratory syncytial virusLaura M Stephens, Steven M Varga
Pageof 10